We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$207B
AUM Growth
+$20.6B
Cap. Flow
+$7.57B
Cap. Flow %
3.65%
Top 10 Hldgs %
26.62%
Holding
9,816
New
1,347
Increased
3,275
Reduced
3,438
Closed
1,488

Sector Composition

Rank Sector Weight
1 Consumer Staples 2.31%
2 Technology 1.26%
3 Financials 1.12%
4 Healthcare 1.04%
5 Consumer Discretionary 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCP
9201
DELISTED
DCP Midstream, LP
DCP
-26,061
Closed -$889K
RUTH
9202
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-42,350
Closed -$648K
DBD
9203
DELISTED
Diebold Nixdorf Incorporated
DBD
-30,865
Closed -$820K
KBAL
9204
DELISTED
Kimball International
KBAL
-28,268
Closed -$322K
MGI
9205
CALL
DELISTED
MoneyGram International, Inc. New
MGI
-33,800
Closed -$232K
SEAC
9206
DELISTED
Seachange International Inc
SEAC
-1,641
Closed -$105K
OIG
9207
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-723
Closed -$146K
OIG
9208
PUT
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-593
Closed -$120K
ALR
9209
DELISTED
AlerisLife Inc
ALR
-6,546
Closed -$153K
ALBO
9210
DELISTED
Albireo Pharma Inc
ALBO
-372
Closed -$3K
SRNE
9211
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-14,851
Closed -$100K
CHAD
9212
PUT
DELISTED
Direxion Daily CSI 300 China A Share Bear 1X Shares
CHAD
-32,100
Closed -$1.4M
REED
9213
CALL
DELISTED
Reeds, Inc. Common Stock
REED
-320
Closed -$40K
ZNH
9214
PUT
DELISTED
China Southern Airlines Company Limited
ZNH
-8,100
Closed -$231K
IVC
9215
CALL
DELISTED
Invacare Corporation
IVC
-89,800
Closed -$1.09M
IVC
9216
PUT
DELISTED
Invacare Corporation
IVC
-18,800
Closed -$228K
DS
9217
DELISTED
Drive Shack Inc.
DS
-14,695
Closed -$68K
HIL
9218
DELISTED
Hill International, Inc. Common Stock
HIL
-25,808
Closed -$112K
RADA
9219
DELISTED
Rada Electronic Industries Ltd
RADA
-12,651
Closed -$15K
ECOM
9220
CALL
DELISTED
CHANNELADVISOR CORPORATION
ECOM
-61,200
Closed -$887K
ECOM
9221
PUT
DELISTED
CHANNELADVISOR CORPORATION
ECOM
-10,000
Closed -$145K
CFMS
9222
DELISTED
Conformis, Inc. Common Stock
CFMS
-2,134
Closed -$429K
CCXI
9223
DELISTED
ChemoCentryx, Inc.
CCXI
-31,052
Closed -$147K
CCXI
9224
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
-11,400
Closed -$51K
MN
9225
DELISTED
MANNING & NAPIER, INC.
MN
-67,271
Closed -$539K

Similar funds

Jeff Yass's Q3 2016 Portfolio in Review

As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.

By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $762M trimmed.

  • Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
  • Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
  • Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
  • Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
  • Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
  • Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
  • Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.

Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.